Tammy Hennika Clinical Oncology Society of Australia Annual Scientific Meeting 2021

Abstracts this author is presenting:

• KEYNOTE-905/EV-303: A Phase 3 Study of Perioperative Pembrolizumab or Pembrolizumab + Enfortumab Vedotin and Cystectomy Versus Cystectomy Alone in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer — e-Poster Listing